• Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to Q1 2012
  • Revenues expected to exceed $11.0 million by the end of June 2013, compared to $7.4 million for the first half of 2012
  • 2013 revenues expected to significantly exceed 2012 revenues
  • IND for PBI-4050 expected to be filed in Q3 2013
  • ProMetic BioProduction's plasma purification and manufacturing facility to be operational in Q4 2013
  • 2013 corporate objectives communicated
  • New members elected to Board of Directors